Personal profile
Biography
Yoga joined the School of Pharmacy at Monash University in 2022. She is a pharmacist who has served in various clinical settings in Malaysia prior transitioning into cancer research in 2016. She is passionate about translational oncology with the believe that a bench to bedside application of scientific discoveries in chemotherapy may improve the treatment outcomes and QOL of cancer patients.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
-
MicroRNA-146b-5p/FDFT1 mediates cisplatin sensitivity in bladder cancer by redirecting cholesterol biosynthesis to the non-sterol branch
Azhar, N. A., Paramanantham, Y., B W M Nor, W. M. F. S. & Nur, N. A., Nov 2024, In: International Journal of Biochemistry & Cell Biology. 176, 13 p., 106652.Research output: Contribution to journal › Article › Research › peer-review
2 Link opens in a new tab Citations (Scopus) -
Spectroscopic diagnosis and metabolite characterization of cisplatin resistance regulated by FDFT1 in bladder cancer tissue
Kanmalar, M., Kamal, R., Abdul Sani, S. F., Pathmanathan, D., Bm Said, N. A., Paramanantham, Y., Abd Jamil, A. H., Mun, K. S., Kuppusamy, S., Almugren, K. S., Almajid, H. F. & Bradley, D. A., Aug 2024, In: Applied Radiation and Isotopes. 210, 111372.Research output: Contribution to journal › Article › Research › peer-review
2 Link opens in a new tab Citations (Scopus) -
The correlation of EMT and p53 immunohistochemical markers with cisplatin resistance in muscle invasive bladder cancer patients: A single-centred study
Paramanantham, Y., B M Said, N. A. & Mun, K. S., 1 Apr 2023, In: The Malaysian Journal of Pathology. 45, 1, p. 19-29 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile -
Correlation of metabolic syndrome with clinicopathological characteristics and treatment outcome in bladder cancer: a retrospective observational study
KL, Y., A, N. A., P, Y., K, S., A, S., S, N., AJ, A. H. & BMS, N. A., 2022, In: Medicine & Health. 17, 1, p. 166-179 14 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile -
The role of tumour microenvironment-driven miRNAs in the chemoresistance of muscle-invasive bladder cancer–a review
Paramanantham, Y., Chung, I. & BM Said, N. A., Apr 2022, In: Urologic Oncology: Seminars and Original Investigations. 40, 4, p. 133-148 16 p.Research output: Contribution to journal › Review Article › Research › peer-review
4 Link opens in a new tab Citations (Scopus)
Activities
-
Judge for the National Pharmacy Debate Competition (NPDC) 2024 (Event)
Paramanantham, Y. (Member)
21 Sept 2024Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board
-
MUM 3MT Competition
Paramanantham, Y. (Speaker)
29 Apr 2024Activity: Other Teaching Engagements and non-HDR Supervisions › Industry projects
-
Joint Webinar between University of Tunku Abdul Rahman (UTAR, Malaysia) and National Cheng Kung University (NCKU, Taiwan)
Paramanantham, Y. (Invited speaker)
23 Apr 2024Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
Evolving Treatment Methodologies in Addiction (ETMA) Conference
Paramanantham, Y. (Organiser)
21 Mar 2024Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
Chevening Alumni Malaysia (CAM) (External organisation)
Paramanantham, Y. (Member)
2017 → 2024Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board
Press/Media
-
Methadone triumph: Revolutionising addiction treatment in Malaysia’
8/05/24
1 Media contribution
Press/Media: Article/Feature